The efficiency of hepatocyte transplantation into the liver varies with the method of administration. This study investigated whether retrograde infusion via the hepatic vein provides a sufficient number of donor cells for the liver. Donor hepatocytes were isolated from dipeptidyl peptidase IV (DPPIV + ) rats and transplanted into DPPIV − rat livers either by antegrade portal vein infusion or retrograde hepatic vein infusion. Hepatocyte engraftment ratios and localization were evaluated by histological DPPIV enzymatic staining at 1 week and 8 weeks after the transplantation. No significant differences in engraftment efficiency were observed at either 1 week or 8 weeks after transplantation by either route. However, the localization of the transplanted hepatocytes differed with the administration route. Portal vein infusion resulted in predominantly periportal engraftment, whereas hepatic vein infusion led to pericentral zone engraftment. Immunohistochemical analysis showed that the transplanted hepatocytes engrafted in the pericentral zone after retrograde infusion displayed intense CYP2E1 staining similar to the surrounding native hepatocytes. CYP2E1 staining was further enhanced by administration of isosafrole, an inducing agent for various cytochrome P450 enzymes, including CYP2E1. This study demonstrates a novel approach of transplanting hepatocytes into the liver through retrograde hepatic vein infusion as the means to target cell implantation to the pericentral zone.
INTRODUCTION
ther a percutaneous transhepatic portal puncture (20,27), a surgical insertion through the middle colic or the inferior mesenteric vein (2, 13, 14, 25) , or an interventional Cell-based transplantation using isolated hepatocytes is an emerging field of clinical therapeutics for treating insertion through the patent umbilical vein in neonatal cases (7, 13) . All these approaches allow the cells to flow liver diseases and disorders (16, 18) . Since the first hepatocyte transplantation in 1992 (15) , more than 80 pa-into the liver in an antegrade direction, leading to the stacking of transplanted donor cells in the portal vein tients have been treated using this approach (3, 7, 17, 28) . In many cases of acute or terminal liver failure, hepato-radicles. Some of these cells can subsequently translocate into the liver parenchyma (6, 26) , and, ultimately, cyte transplantation has been successfully adopted as a temporary measure until liver transplantation can be per-the hepatocytes predominantly engraft in the periportal area known as zone 1 (5, 26) . The portal circulation ap-formed (20, 23, 28) . Accumulating evidence also suggests that hepatocyte transplantation can be therapeutic in var-proach may carry the risks associated with surgical procedures, and can cause temporary portal hypertension ious inherited liver-based metabolic disorders (13, 17, 20) . In some cases, hepatocyte transplantation provided and possible embolization (6, 21) . A promising alternative method for transplanting marked clinical improvement by stabilizing or even correcting the pathological phenotype without the need for liver cells is retrograde infusion into the hepatic vein, which is widely used in interventional radiological pro-subsequent liver transplantation (4, 23, 27) .
In current experimental and clinical applications, he-cedures. A balloon catheter is placed into the hepatic vein through the jugular vein in order to allow retro-patocytes are transplanted through the portal circulation (14, 17, 21, 29) , which is accessed with a catheter by ei-grade perfusion of the contrast media for imaging the 1260 GOTO ET AL.
liver parenchyma with minimally invasive procedures (5 ml) for 60 s. Immediately after the saline infusion, the inserted catheter and the rubber bands were removed (11, 19) . Cell transplantation into the liver by retrograde infusion though the hepatic vein may be a viable and from the SHVC and the IHVC to allow blood flow the liver. The infusion was done within 60 s to minimize safe strategy. Therefore, the present study used rats to investigate the engraftment efficiency of hepatocytes possible liver damage. Sham operations were also performed using 0.5 ml cell-free saline instead of 0.5 ml transplanted via retrograde perfusion. hepatocyte suspension.
MATERIALS AND METHODS

Biochemical Analysis of Rat Serum Animals
Blood samples were obtained from the retro-orbital Male dipeptidyl peptidase IV-positive (DPPIV + ) plexus of the recipient rats at 3 and 7 days after the F344/NSlc rats (8-12 weeks old) were obtained from transplantation. After centrifugation, serum samples Japan SLC (Hamamatsu, Japan) and were used as the were analyzed for aspartate aminotransferase (AST), alhepatocyte donors in this study. Male DPPIV-negative anine aminotransferase (ALT), total bilirubin (T-Bil), (DPPIV − ) F344/DuCrlCrlj rats (8-12 weeks old) were and serum albumin (ALB) levels with the clinical anaobtained from Charles River Japan (Yokohama, Japan).
lyzer DRI-CHEM 3500i (Fujifilm, Tokyo, Japan) to de-These DPPIV − rats have a syngeneic background to the termine the extent of liver injury related to the cell transdonor rats, and were used as the recipient animals. All plantation. animal procedures were conducted in accordance with the institutional guidelines set by the Tokyo Women's Histological Analyses of Transplanted Hepatocytes Medical University Animal Care Committee. Rats were Recipient rats were sacrificed 24 h, 1 week, or 8 kept in cages in a temperature-controlled room with a weeks after transplantation. Three separated liver lobes 12-h light/dark cycle and ad libitum access to food and (medial, left lateral, and right lateral lobes) and the lungs water.
were rapidly frozen in OCT compound (Sakura Finetek, Tokyo, Japan). DPPIV enzymatic staining was per-Hepatocyte Isolation and Purification formed using 5-µm sections from the frozen specimens Hepatocytes were isolated and purified from the as previously described (1,6,26). The engraftment ratios DPPIV + rats by using a modified two-step collagenase of the donor hepatocytes in the recipient liver were deperfusion method as previously described (24). Cells termined by counting the number of DPPIV + cells and were resuspended in DMEM (Sigma-Aldrich, St. Louis, expressed as the percentage of DPPIV + cells per total MO) at 2 × 10 7 cells/ml, and cell viability was deternumber of DPPIV − and DPPIV cells (approximately mined by trypan blue exclusion. In this study, experi-24,000 cells from 30 random areas of the specimens ments were conducted only when hepatocyte purity and from three liver lobes). The ratio of DPPIV + hepatocytes viability exceeded 98% and 90%, respectively. in a specific area was also obtained. The locations of the engrafted hepatocytes were marked as liver zone 1 Hepatocyte Transplantation (periportal venous area), zone 2 (intermediate area), or zone 3 (pericentral venous area) (21, 22) . Hepatocytes from donor DPPIV + rats were transplanted into recipient DPPIV − rat livers (5 × 10 4 cells/g Cytochrome P450 Induction rat body weight) through two different routes: the portal vein (antegrade) or the hepatic vein (retrograde). For the To investigate the zone-specific drug-metabolizing function of the engrafted hepatocytes, recipient rats were portal vein method, hepatocytes were infused at the rate of 0.5 ml/min following the insertion of a 27-gauge nee-given IP isosafrole (150 mg/kg body weight; Wako Pure Chemical, Osaka, Japan) dissolved in corn oil as pre-dle. For the hepatic vein method (Fig. 1A) , the infrahepatic vena cava (IHVC) and suprahepatic vena cava viously described (n = 5) (9). Injections were performed for 3 consecutive days starting 12 days after transplanta-(SHVC) were isolated from the surrounding tissues, and rubber bands were placed around the veins. An 18-gauge tion. Control rats were also treated with corn oil or isosafrole as described above (n = 5). All the rats were sac-plastic catheter was inserted into the vena cava from beneath the isolated IHVC, and the catheter tip was placed rificed 24 h after the final injection. Liver pieces were resected from the three separate liver lobes of the recipi-between the isolated SHVC and IHVC. Prior to cell infusion, the SHVC and IHVC were temporarily clamped ent rats for double immunohistochemical analysis of cytochrome P450 subtype 2E1 (CYP2E1) and DPPIV (12) . by tying the rubber bands to avoid infusion into vessels other than the hepatic veins. Cells were infused through Frozen 5-µm-thick sections were fixed with cold acetone and incubated with rabbit anti-rat CYP2E1 anti-the catheter, followed by an additional infusion of saline body (1:200; Millipore, Billerica, MA, USA) and puri-and T-Bil were determined at day 0 (prior to the infusion), and 3 and 7 days after hepatocyte transplantation fied mouse anti-rat CD26 antibody (BD Biosciences, San Jose, CA, USA). For fluorescence immunohisto-through both the antegrade and retrograde procedures (Fig. 2 ). Acute transient injury was detected by elevated chemistry, Alexa Fluor 488 goat anti-mouse IgG (Invitrogen, Carlsbad, CA, USA) and Alexa Fluor 594 goat AST levels on day 3 regardless of the transplantation procedure, which is consistent with previous studies anti-rabbit IgG (Invitrogen) were used as the secondary antibodies. Nuclear DNA was stained with 4′,6-diamid- (31) . The AST values returned to normal by day 7 in all the groups. No impairment of liver function, represented ino-2-phenylindole (DAPI).
The stained samples were digitally photographed, and by the ALT, ALB, and T-bil levels, was observed in any of the groups (Fig. 2 ). the intensity of CYP2E1 staining in the hepatocytes was evaluated by an image analysis software (Scion Image;
Engraftment of Hepatocytes Transplanted Scion Corporation, Frederick, MD). Fluorescence intenby Retrograde Infusion sity was measured in 10 randomly selected fields of zone 1, 2, and 3 in each rat (a total of 30 fields/rat).
To determine the feasibility of hepatocyte transplantation using retrograde infusion via the hepatic vein, en-X-Ray Computed Tomography graftment of the transplanted cells was evaluated 1 week To rule out lung embolism and infarction, contrastafter transplantation. At that time, histological examinaenhanced computed tomography (CT) scanning was pertion revealed that the donor hepatocytes transplanted via formed 24 h after hepatocyte transplantation. A total antegrade infusion were predominantly engrafted in the volume of 3 ml of contrast medium (Iomelon350; Eizai, liver parenchyma at the periportal venous area (zone 1) Tokyo, Japan) was administered by IV injection through ( Fig. 3A-D) . In contrast, the hepatocytes transplanted the animal's tail vein at a flow rate of 0.2 ml/s. The CT via retrograde infusion were located in the pericentral images were obtained on a micro-X-ray CT device used venous area (zone 3) ( Fig. 3A-D) . The engraftment rafor laboratory animals (R-mCT; Rigaku, Tokyo, Japan) tios of the transplanted hepatocytes were 0.28 ± 0.11% immediately after the contrast injection under inhalation and 0.30 ± 0.13% in the antegrade and retrograde infuanesthesia. sion groups, respectively ( Fig. 3E ); no significant differences were observed between these two groups. The Statistical Analysis engraftment ratio was calculated as the number of en-All values calculated in the present study are mean grafted donor hepatocytes (DPPIV + hepatocytes) divided (SD). The significance of the differences among the by the total number of hepatocytes (both recipient and groups was tested by one-way or two-way ANOVA foldonor, DPPIV − and DPPIV + hepatocytes) in each rat. A lowed by either Dunnett's or Tukey-Kramer post hoc possible procedure-dependent difference in the zonal lotest using the Statview 5.0 software (SAS Institute, calization of hepatocyte engraftment was also examined. Cary, NC, USA). A probability value of p < 0.05 was Figure 3F shows a marked difference in the zonal districonsidered to be statistically significant.
bution of engrafted hepatocytes depending on the transplantation procedure. Most (75.8%) of the engrafted he-RESULTS patocytes infused through the portal vein were found Retrograde Hepatocyte Transplantation within zone 1. In contrast, 69.0% of the engrafted hepatocytes transplanted through the hepatic vein localized As shown in Figure 1A , a catheter was inserted between the SHVC and IHVC, and the vessels were tem-to zone 3. porarily clamped with rubber bands to selectively infuse Long-Term Survival of the Hepatocytes Transplanted the donor hepatocytes into the liver through the hepatic by Hepatic Vein Infusion veins in a retrograde manner. As the infusion progressed, the liver swelled and became light red, indicat-
To determine the long-term survival of the engrafted hepatocytes, the recipient animals' livers were dissected ing that the infused solution was entering the liver from the hepatic veins ( Fig. 1B-D) . Immediately after the 8 weeks following antegrade or retrograde infusion. At week 8, DPPIV + transplanted hepatocytes were detected clamps were removed, the blood flow to the liver returned to normal (data not shown), and the rats recov-in the recipient liver parenchyma in both the antegrade and retrograde infusion groups (Fig. 3G, H) . The en-ered within several minutes after the surgical procedure. None of the rats died during this retrograde infusion pro-graftment ratios of the antegrade and retrograde groups were 0.26 ± 0.05% and 0.35 ± 0.15%, respectively (Fig. cedure.
To determine any adverse effects on the liver from 3I). The hepatocytes transplanted by antegrade and retrograde infusion were found predominantly in zones 1 the surgical procedure, the serum levels of AST, ALT, and infrahepatic vena cava (IHVC) were isolated from the surrounding tissue, and rubber bands were placed around the veins ("clamping point"). An 18-gauge angiocatheter was inserted into the vena cava from beneath the IHVC, and the catheter tip was placed between IHVC and SHVC. IHVC and SHVC were temporarily clamped with the rubber bands. Hepatocytes were infused through the catheter for 60 s at a dose of 5 × 10 4 cells/g body weight (total volume 0.5 ml), followed by an additional infusion of 5 ml of saline for 60 s. (B-E) Live images of the retrograde hepatocyte transplantation procedure. SHVC (B) and IHVC (C) were temporarily clamped by rubber bands after the insertion of the angiocatheter from IHVC (D). (E) Upon cell and saline infusion, the liver gradually swelled and turned slightly red. PV, portal vein. Scale bars: 1 cm. and 3, respectively. No apparent alteration of hepatocyte portal-central axis (12) . Xenobiotic metabolism occurs predominantly in the hepatocytes located in zone 3. Cy-localization was seen 8 weeks after transplantation (Fig. 3J) .
tochrome P450 2E1 (CYP2E1) is an important enzyme involved in xenobiotic metabolism. We first investigated Conservation of the Drug-Metabolizing Function the expression of this enzyme in the livers of animals of the Transplanted Hepatocytes who did not undergo transplantation. CYP2E1 expression was highest in zone 3 in nontreated rats, and formed Metabolic zonation of the liver is characterized by nonuniform distribution of metabolic enzymes along the a decreasing gradient from zone 3 to zone 1 (Fig. 4A ).
CYP2E1 expression levels were similar in the livers of isosafrole into the IP space of recipient rats 2 weeks after transplantation. The hepatocytes engrafted in zone rats treated with corn oil and untreated rats (Fig. 4B) . In marked contrast, treatment with the CYP2E1-inducing 3 demonstrated strong CYP2E1 staining similar to that of the surrounding native hepatocytes (Fig. 4K, L) . Ana-agent isosafrole strongly increased CYP2E1 expression, particularly in zone 3 (Fig. 4C) . Quantifying the fluores-lyzing the fluorescence intensity of CYP2E1 in livers of recipient rats with Scion Image revealed that hepato-cence intensity of CYP2E1 with the Scion Image software also revealed a clear increase in intensity in zones cytes engrafted in zone 3 by retrograde infusion had stronger CYP2E1 staining and a higher degree of isosaf-2 and 3 in isosafrole-treated rats compared to ones that did not receive isosafrole (Fig. 4D) .
role induction than donor hepatocytes transplanted via antegrade infusion (Fig. 4M ). Furthermore, fluorescence DPPIV + donor hepatocytes that localized to zone 1 after infusion through the portal vein were weakly posi-intensity analysis showed that CYP2E1 expression in hepatocytes transplanted by retrograde infusion was tive for CYP2E1, similar to the surrounding native hepatocytes regardless of the isosafrole treatment ( Fig. 4E equivalent to that of the surrounding native hepatocytes in the liver of rats treated with isosafrole ( Fig. 4M ). H). In contrast, DPPIV + hepatocytes engrafted in zone 3 showed stronger CYP2E1 staining (Fig. 4I, J) compared
These results indicate that donor hepatocytes engrafted in zone 3 after retrograde infusion were able to to the donor hepatocytes in zone 1 (Fig. 4E, F) . To evaluate the functionality of hepatocytes engrafted in zone survive long term and to maintain drug-metabolizing activity similar to that of the native hepatocytes. 3, which takes up circulating xenobiotics, we injected 
Complications and Side Effects of Retrograde Infusion DISCUSSION
The present study analyzed a novel cell transplanta-Some donor hepatocytes transplanted via retrograde infusion are likely to flow into the lungs through the tion approach that allowed hepatocytes to be infused in a retrograde manner through the hepatic vein to the liver inferior vena cava (IVC). Therefore, we investigated whether pulmonary embolism or infarction occurred 24 parenchyma. Our results show that retrograde infusion of hepatocytes resulted in cellular engraftment predomi-h after retrograde infusion. Histological staining of the sagittal sections of the lung for DPPIV after retrograde nantly in zone 3 of the liver, an area of robust xenobiotic metabolism. The hepatocytes engrafted in zone 3 sur-infusion showed approximately 20 donor hepatocytes in the lung (Fig. 5A, B ). However, H&E staining revealed vived for up to 8 weeks after transplantation, and were functionally capable of xenobiotic uptake and CYP2E1 no karyolysis around the transplanted hepatocytes, indicating that no pulmonary infarction occurred (Fig. 5C , expression. Previous hepatocyte transplantations for experimental D). The number of donor hepatocytes in the lung decreased to four to five 1 week after retrograde infusion and clinical applications have mostly been delivered by antegrade infusion through the portal vein (7,14,17,21, (Fig. 5E, F) .
We also investigated the possible occurrence of em-25,29). Antegrade infusion results in hepatocyte accumulation at the periphery of the portal pedicles, and bolism or infarction with contrast-enhanced computed tomography (CT) 24 h after hepatocyte transplantation. some of the hepatocytes enter the hepatic sinusoids and integrate with the parenchymal plates (5, 26) . The results Compared with control rats, no circulation abnormalities and no pulmonary embolism or infarction were found in of our study are consistent with these previously published studies documenting donor hepatocyte engraft-the lung 24 h after retrograde hepatocyte infusion (Fig.  5G, H) . ment predominantly in zone 1 (5,26). In contrast, retrograde infusion of hepatocytes through transplanted by retrograde infusion survived for up to 8 weeks, indicating that our procedure may be a viable the hepatic vein resulted in engraftment predominantly in zone 3. The infused hepatocytes were speculated to clinical cell transplantation approach. Moreover, zone 3 of the liver is an active site for xenobiotic metabolism enter into the periphery of the hepatic vein and subsequently migrate into the hepatic sinusoid for transport (12) , and zone 3 hepatocytes have higher levels of many members of cytochrome P450 compared to the hepato-into the parenchymal plates. Engrafted hepatocytes cytes in zones 1 and 2 (9, 12) . Although the mechanisms Further studies and improvements, and careful risk assessments, are required before our retrograde infusion underlying the differences in xenobiotics metabolism among the 3 zones are unknown, the histological struc-technique can be used in clinical applications. The number of hepatocytes to be used in infusion, the flow rate ture and different arrangement of the liver sinusoidal endothelial cells could account for this disparity (10) . Zone and pressure of the injected solution, and the method for regulating portal vein pressure all require careful optimi-3 sinusoidal endothelial cells have larger and more numerous fenestrae than do cells in zones 1 and 2 (10, 30) .
zation. Currently, cell transplantation into the liver has gained attention, and such techniques are being used to These zone-dependent characteristics of the fenestrae allow the zone 3 hepatocytes to contact and uptake xe-transplant islet cells to treat type 1 diabetes mellitus. These procedures are generally conducted using ante-nobiotic compounds at higher rates than their counterparts in zones 1 and 2. The periportal-to-perivenous gra-grade infusion through the portal vein. Our findings will be helpful in future efforts to transplant islet cells via dients of oxygen, hormones, and nutrients carried by the blood are also associated with the functional differences retrograde infusion to minimize liver injury and preserve the function of the donor cells. of the hepatocytes in the zones of the liver (10) . In this study, the hepatocytes engrafted in zone 3 (transplanted In conclusion, ours is the first report to successfully demonstrate that retrograde infusion into the liver can through the hepatic vein) expressed levels of CYP2E1 similar to the levels expressed by surrounding native he-be a viable method of cell transplantation. We demonstrate that retrograde infusion provides efficient hepato-patocytes in response to isosafrole. On the other hand, hepatocytes engrafted in zone 1 (transplanted through cyte engraftment into zone 3 of the liver parenchyma. In current liver-targeted cell therapies, including islet and the portal vein) expressed much lower levels of CYP2E1. These results show that the target localization of hepato-hepatocyte transplantations, cells are traditionally infused into the liver through the portal vein, but the find-cyte engraftment should be considered according to the function desired from the engrafted cells. Our findings ings of this study show that similarly effective cell transplantation can be achieved in a less invasive manner. indicate that retrograde infusion of hepatocytes could have an advantage over antegrade infusion in treating
Although further studies will be required to address the therapeutic potential of retrograde infusion in various liver diseases or disorders that require high rates of drug metabolism.
diseases, this new transplantation approach is an important step in the further development of innovative strate-Some transplanted hepatocytes could flow into the IVC and the lungs after retrograde infusion. However, gies for hepatocyte and islet cell transplantation therapies. histological examination and contrast-enhanced CT revealed no pulmonary embolism or infarction in the ACKNOWLEDGMENTS: The authors would like to thank lungs. Since blood from the bronchial artery can often catheter to promote selective liver transfection in pigs.
